Cell proliferation, apoptosis, migration, invasion and epithelial-to-mesenchymal transition (EMT) after SPRY4-IT1 silencing were assessed, which implied that SPRY4-IT1 might exert oncogenic properties in CCA. Here, SPRY4 is linked to cholangiocarcinoma.